| Outcomes of kidney transplantation in HIV-infected recipients PG Stock, B Barin, B Murphy, D Hanto, JM Diego, J Light, C Davis, ... New England Journal of Medicine 363 (21), 2004-2014, 2010 | 552 | 2010 |
| HIV-infected liver and kidney transplant recipients: 1-and 3-year outcomes ME Roland, B Barin, L Carlson, LA Frassetto, NA Terrault, R Hirose, ... American Journal of Transplantation 8 (2), 355-365, 2008 | 278 | 2008 |
| Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection NA Terrault, ME Roland, T Schiano, L Dove, MT Wong, F Poordad, ... Liver transplantation 18 (6), 716-726, 2012 | 200 | 2012 |
| Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers G Mutua, E Sanders, P Mugo, O Anzala, JE Haberer, D Bangsberg, ... PloS one 7 (4), e33103, 2012 | 180 | 2012 |
| Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and … BS Peters, W Jaoko, E Vardas, G Panayotakopoulos, P Fast, C Schmidt, ... Vaccine 25 (11), 2120-2127, 2007 | 125 | 2007 |
| Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa W Jaoko, FN Nakwagala, O Anzala, GO Manyonyi, J Birungi, A Nanvubya, ... Vaccine 26 (22), 2788-2795, 2008 | 105 | 2008 |
| Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV … FM Kibengo, E Ruzagira, D Katende, AN Bwanika, U Bahemuka, ... PloS one 8 (9), e74314, 2013 | 102 | 2013 |
| A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults MC Keefer, J Gilmour, P Hayes, D Gill, J Kopycinski, H Cheeseman, ... Public Library of Science 7 (8), e41936, 2012 | 101 | 2012 |
| MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates A Subramanian, M Sulkowski, B Barin, D Stablein, M Curry, N Nissen, ... Gastroenterology 138 (1), 159-164, 2010 | 90 | 2010 |
| Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls ME Roland, B Barin, S Huprikar, B Murphy, DW Hanto, E Blumberg, ... Aids 30 (3), 435-444, 2016 | 75 | 2016 |
| Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients PG Stock, B Barin, H Hatano, RL Rogers, ME Roland, TH Lee, M Busch, ... American journal of transplantation 14 (5), 1136-1141, 2014 | 74 | 2014 |
| Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a … B Barin, U Kasap, F Selçuk, E Volkan, Ö Uluçkan The Lancet Microbe 3 (4), e274-e283, 2022 | 63 | 2022 |
| Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr. HIVA DNA and MVA. HIVA vaccines in a prime-boost strategy to induce HIV-1 … A Guimaraes-Walker, N Mackie, S McCormack, T Hanke, C Schmidt, ... Vaccine 26 (51), 6671-6677, 2008 | 63 | 2008 |
| Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr. HIVA DNA and MVA. HIVA vaccines in a prime-boost strategy to induce HIV-1 … A Guimaraes-Walker, N Mackie, S McCormack, T Hanke, C Schmidt, ... Vaccine 26 (51), 6671-6677, 2008 | 63 | 2008 |
| A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine S Mehendale, J Van Lunzen, N Clumeck, J Rockstroh, E Vets, ... AIDS research and human retroviruses 24 (6), 873-880, 2008 | 58 | 2008 |
| A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers VD Ramanathan, M Kumar, J Mahalingam, P Sathyamoorthy, ... AIDS research and human retroviruses 25 (11), 1107-1116, 2009 | 57 | 2009 |
| Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial WA Brooks, K Zaman, KDC Lewis, JR Ortiz, D Goswami, J Feser, ... The Lancet Global Health 4 (12), e946-e954, 2016 | 56 | 2016 |
| Understanding adherence to daily and intermittent regimens of oral HIV pre-exposure prophylaxis among men who have sex with men in Kenya PM Mugo, EJ Sanders, G Mutua, E van der Elst, O Anzala, B Barin, ... AIDS and Behavior 19, 794-801, 2015 | 48 | 2015 |
| First-in-human evaluation of the safety and immunogenicity of an intranasally administered replication-competent Sendai virus–vectored hiv type 1 gag vaccine: Induction of … J Nyombayire, O Anzala, B Gazzard, E Karita, P Bergin, P Hayes, ... The Journal of Infectious Diseases 215 (1), 95, 2017 | 44 | 2017 |
| Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults G Mutua, B Farah, R Langat, J Indangasi, S Ogola, B Onsembe, ... Molecular therapy Methods & clinical development 3, 2016 | 44 | 2016 |
